Straits Times Index
3,344.06 +12.36 (+0.37%) Nikkei
39,341.54 -325.53 (-0.82%) Hang Seng
17,708.78 -381.15 (-2.11%) FTSE 100
8,220.73 -4.60 (-0.06%) Bitcoin USD
60,693.79 -1,018.39 (-1.65%) CMC Crypto 200
1,261.73 -4.41 (-0.35%)
INN Dec 2024 5.000 call
- PR Newswire
SUMMIT HOTEL PROPERTIES ANNOUNCES SECOND QUARTER 2024 EARNINGS RELEASE DATE
Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that it will report financial results for the second quarter of 2024 on Monday, July 29, 2024, after the market closes.
- Zacks
Should Value Investors Buy Summit Hotel Properties (INN) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- CNW Group
Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the success and conclusion of a preliminary safety evaluation of Innocan's single injection and sustained-release LPT-CBD conducted on minipigs. The animals demonstrated excellent drug tolerance and did not exhibit any drug-related adverse events.
